Jan Eickhoff
Impact in
- Immunology top 5%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Molecular Biology top 5%
- Inflammasome and immune disorders
- 14-3-3 protein interactions
- Protein Degradation and Inhibitors
Papers in
- Epidemiology 12
- Cytomegalovirus and herpesvirus research 12
-
- Synthesis and biological activity 7
- Synthesis and Characterization of Heterocyclic Compounds 4
- Co-authors
- Bert Klebl (20 shared papers)Peter Habenberger (6 shared papers)Axel Choidas (4 shared papers)Susanne Kordes (3 shared papers)Sascha Menninger (3 shared papers)Raffaella Di Lucrezia (1 shared paper)Alf Herzig (1 shared paper)Peter Nußbaumer (1 shared paper)
- Journals
- Journal of Biological Chemistry (6 papers)Journal of Medicinal Chemistry (3 papers)Antiviral Research (2 papers)European Journal of Medicinal Chemistry (2 papers)Pharmaceutics (2 papers)
- Partner nations
- GermanyNorwayUnited States
In The Last Decade
Jan Eickhoff
43 papers receiving 2.6k citations
Jan Eickhoff's Hit Papers
Peers
Comparison fields: 5 of 91
- Immunology 547
- Molecular Biology 1.1k
- Oncology 262
- Epidemiology 292
- Organic Chemistry 237
Countries citing papers authored by Jan Eickhoff
This map shows the geographic impact of Jan Eickhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Eickhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Eickhoff more than expected).
Fields of papers citing papers by Jan Eickhoff
This network shows the impact of papers produced by Jan Eickhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Eickhoff. The network helps show where Jan Eickhoff may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Eickhoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gasdermin D plays a vital role in the generation of neutrophil extracellular traps Hit paper breakdown → | 2018 | 641 |
| 2 | 2014 | 389 | |
| 3 | 2017 | 234 | |
| 4 | 2017 | 166 | |
| 5 | 2017 | 144 | |
| 6 | 2013 | 105 | |
| 7 | 2015 | 95 | |
| 8 | 2005 | 89 | |
| 9 | 2008 | 75 | |
| 10 | 2014 | 69 | |
| 11 | 2009 | 49 | |
| 12 | 2019 | 49 | |
| 13 | 2017 | 46 | |
| 14 | 2002 | 41 | |
| 15 | 2008 | 34 | |
| 16 | 2011 | 33 | |
| 17 | 2004 | 31 | |
| 18 | 2021 | 29 | |
| 19 | 2018 | 28 | |
| 20 | 2019 | 28 |
About Jan Eickhoff
Jan Eickhoff is a scholar working on Epidemiology, Organic Chemistry, Molecular Biology, Computational Theory and Mathematics and Pathology and Forensic Medicine, having authored 43 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (12 papers), Synthesis and biological activity (7 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers), Computational Drug Discovery Methods (4 papers), Cancer-related Molecular Pathways (3 papers), 14-3-3 protein interactions (3 papers), Protein Degradation and Inhibitors (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Immunology (547 citations), Molecular Biology (1.1k citations), Oncology (262 citations), Epidemiology (292 citations) and Organic Chemistry (237 citations). Jan Eickhoff has collaborated with scholars based in Germany, Norway and United States. Frequent co-authors include Bert Klebl, Peter Habenberger, Axel Choidas, Susanne Kordes, Sascha Menninger, Raffaella Di Lucrezia, Alf Herzig, Peter Nußbaumer, Arturo Zychlinsky and Renate Krüger. Their work appears in journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry, Antiviral Research, European Journal of Medicinal Chemistry and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.